← Back to recalls

iLet Bionic Pancreas, REF: BB1001

Class II
Recalling firm
Beta Bionics, Inc.
Reason for recall
insulin pump software versions 1.4.2, and 1.4.3 issue with Dexcom Continuous Glucose Monitoring (CGM) G7 sensor may result in delayed CGM reading then switch to non-CGM dosing, leading to only basal/requested meal doses provided, no correction doses/insulin reductions/suspensions for high/low glucose unless blood glucose entered for sensor life or replacement. Potential health risks to users include severe hyperglycemia with and without DKA and severe hypoglycemia.
Distribution pattern
US Nationwide distribution in the states of TX, PA, AL, MI, OH, FL, TN, GA.
State
CA
Status
Ongoing
Recall number
Z-1996-2026
Recall initiated
March 12, 2026
View on openFDA